22NW, LP
In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), 22NW, LP reported 13 stock positions worth $117.2 million. Its top holding was Foster (lb) Class A (FSTR) at 24.1% of the portfolio, followed by Lifecore Biomedical (LFCR, 20.5%) and Anebulo Pharmaceuticals (ANEB, 12.5%). Compared with Q1 2024, it opened 1 new position and sold out of 1. The biggest buy was a new position in Dhi (DHX) and the biggest sale an exit from Orion (OEC).
- Most Recent 13F
- Q2 2026
- Location
- SEATTLE, WA
- CIK
- 0001694297
- Portfolio Value
- $117.2M (Q2 2024)
- SEC Filing
- 0001214659-24-014708 ↗ filed Aug 14, 2024
Holdings Value
Holdings 13 stocks · $117.2M
| FSTR Foster (lb) Co. Class A | 24.11% | 1,313,121 | $28.3M | No change |
| LFCR Lifecore Biomedical Inc. | 20.48% | 1,755,161 | $24.0M | No change |
| ANEB Anebulo Pharmaceuticals Inc. | 12.50% | 5,366,290 | $14.6M | No change |
| STRL Sterling Infrastructure Inc. | 10.07% | 99,783 | $11.8M | No change |
| BBSI Barrett Business SVCS Inc. | 7.41% | 264,904 | $8.7M | No change |
| CULP Culp Inc. | 4.73% | 1,236,789 | $5.5M | No change |
| PFX Phenixfin Corp. | 4.70% | 117,885 | $5.5M | No change |
| FARM Farmer Bros Co. | 4.47% | 1,955,526 | $5.2M | No change |
| DHX Dhi Group Inc. | 3.69% | 2,068,490 | $4.3M | New |
| MTW Manitowoc Company Inc. | 3.50% | 356,115 | $4.1M | No change |
| LNTH Lantheus Holdings Inc. | 2.37% | 34,562 | $2.8M | No change |
| SSKN Strata Skin Sciences Inc. | 1.41% | 536,995 | $1.6M | No change |
| PMDI Psychemedics Corp. | 0.57% | 274,418 | $664K | No change |
Portfolio Sells Q1 2024 → Q2 2024
| OEC Orion SA | Sold out | 0.00% | −6.86 |
Portfolio Buys Q1 2024 → Q2 2024
| DHX Dhi Group Inc. | New | 3.69% | +3.69 |
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 14 | $104.7M | NSP, NKTR, SRI, FOXF, CMT |
| Q1 2026 | 16 | $145.9M | FSTR, NKTR, LFCR, NSP, MLYS |
| Q4 2025 | 20 | $237.6M | ANEB, FSTR, LFCR, NKTR, RGNX |
| Q3 2025 | 21 | $212.3M | ANEB, FSTR, LFCR, NKTR, SRI |
| Q2 2025 | 21 | $158.8M | FSTR, LFCR, ANEB, SRI, DHX |
| Q1 2025 | 20 | $149.1M | LFCR, FSTR, ANEB, STRL, CULP |
| Q4 2024 | 16 | $158.5M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q3 2024 | 13 | $119.3M | FSTR, LFCR, STRL, CULP, ANEB |
| Q2 2024 | 13 | $117.2M | FSTR, LFCR, ANEB, STRL, BBSI |
| Q1 2024 | 13 | $116.1M | FSTR, ANEB, STRL, LFCR, BBSI |